Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pivot Pharmaceuticals Inc. PVOTF

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Named to the CSE25 Index

Posted on March 27, 2018 by MissionIR

Pivot Pharmaceuticals attains prestigious CSE25 status Recent acquisitions have extended the company’s portfolio in the cannabis space Numerous pharmaceutical and nutraceutical products in development pipeline Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) announced on March … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Completes Integration of California Subsidiary

Posted on March 26, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has successfully completed the integration of its California subsidiary, ERS Holdings Ltd., under the guidance of Patrick Rolfes, president of Pivot Pharmaceuticals USA. … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Named to the CSE25 Index

Posted on March 19, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced that, effective March 16, 2018, the company has been named to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Posted on March 15, 2018 by MissionIR

Owns worldwide rights for patented formulations and drug delivery technologies Develops and commercializes therapeutic pharmaceuticals and nutraceuticals Strategic agenda to become one of world’s only vertically integrated cannabis biotechs With worldwide rights for unique drug delivery platforms in place, Pivot … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Finding Ever-Growing Ways to Administer Cannabis Benefits

Posted on March 13, 2018 by MissionIR

Pivot Pharmaceuticals developing disruptive formulations for cannabis-infused markets Company’s goal is to strengthen dosage predictability and improve product stability Recent acquisitions and planned acquisitions give Pivot vertical position in multi-billion-dollar industries Despite recent setbacks to efforts seeking broader marijuana legalization … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Preparing to File Dealer’s License Application for Agro-Biotech Inc.

Posted on March 12, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced that it has retained Cannabis Compliance Inc. (“CCI”) in order to submit an application, on behalf of Agro-Biotech Inc., to Health Canada for a dealer’s license under … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Announces Acquisition of Thrudermic, LLC

Posted on March 6, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced its acquisition of Thrudermic, LLC, a privately-held North Carolina company. Per the update, Pivot will pay $1.00 for all of the listed and outstanding units of Thrudermic … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Successfully Completes C$5M Private Placement of Convertible Debentures

Posted on March 5, 2018 by MissionIR

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) this morning announced the closing of its private placement of convertible debentures for gross proceeds totaling C$5 million. The company issued a total of C$5 million of 10% senior secured convertible debentures which will … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Completes Acquisition of ERS Holdings; Announces Private Placement of Convertible Debentures

Posted on February 27, 2018 by MissionIR

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced the successful completion of its acquisition of ERS Holdings, LLC (“ERS”). ERS, a privately-held California company, has developed a patented technology called Ready-To-Infuse-Cannabis (“RTIC”) which covers the transformation of cannabis … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Advances CBD Therapy Delivery Options

Posted on February 26, 2018 by MissionIR

Forecasts envision medical cannabis market reaching $55.8 billion by 2025 PVOTF filing patents for smoked, transdermal and mucosal delivery of therapeutics Global partnerships and acquisitions open windows of opportunity for company With its recently announced plan to acquire Agro-Biotech, a … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment